Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Its safety profile is generally favorable, but several specific considerations deserve clinician attention particularly around copper biology, zinc balance, and the small number of patient populations where caution or contraindication applies
For approval and availability in India, a cancer vaccine must: Complete well-designed human clinical trials Demonstrate safety and efficacy Receive CDSCO approval Undergo ethical and regulatory review No CDSCO approval exists No Indian clinical trials are registered No official availability timeline has been announced Any claims suggesting immediate access should be treated with caution
These injections are ideal for clients experiencing fatigue, low energy, or symptoms related to B12 deficiency - which is common among those with dietary restrictions, digestive issues, or increased stress levels
It is not FDA-approved, is research-use-only, and is not for human consumption
